Individuals still saw TB incidence reduction of two-thirds, but effect was not durable
Preliminary results from the Thibela Project – which looked at whether community-wide provision of isoniazid preventive therapy (IPT) in South African gold mines would improve TB control in these high-incidence sites…
At the 19th Conference on Retroviruses and Opportunistic Infections in Seattle, Dr. Helen Ayles presented some key results on behalf of the ZAMSTAR team from the first randomized trial of a combined HIV and TB intervention strategy to demonstrate a reduction in population prevalence of tuberculosis. The study, conducted in 24 communities in Zambia and […]
Treating patients co-infected with HIV and tuberculosis (TB) can be tricky – as rifampin, a key sterilizing drug in TB regimens – can reduce concentrations of antiretrovirals administered at the same time, as well as other drug-drug complications. Early efforts to combat this phenomenon have unearthed a potential treatment candidate – an increased dose of […]
HIV
Leader Needed to Fight Another Pandemic: HIV – While the COVID-19 pandemic has disrupted HIV services worldwide, the office of U.S. Global AIDS Coordinator has remained […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]